This issue of PET Clinics examines the Contribution of FDG to Modern Medicine. In the first of two issues, articles include: The Basic Principles of FDG-PET/CT Imaging; FDG-PET in Diffuse Large B-cell Lymphoma; FDG-PET in Thoracic Malignancies; FDG-PET/CT in Gastrointestinal Malignancies; FDG-PET/CT in Infectious and Inflammatory Diseases; FDG in Urologic Malignancies; FDG-PET for Interventional Oncology in Liver Malignancy; FDG-PET in Neurology and Psychiatry, and more!

Part II of the important issue on Contribution of FDG to Modern Medicine. Articles will include: FDG in infectious/inflammatory diseases, FDG in cardiovascular disease, Assessment of treatment response using PET, PET based chemotherapy response assessment, PET based radiation therapy planning, PET based interventional radiology, PET/MRI, Evolving and upcoming applications of FDG-PET in medicine, and more.

This two-part issue, edited by Dr. Rathan Subramaniam, reviews current clinical information in "PET/CT and Patient Outcomes." In Part I of this issue, articles will include: Head and Neck Cancer, Lung Cancer, Esophageal Cancer, Breast Cancer, Lymphoma, Melanoma, Prostate Cancer, Multiple Myeloma, Thyroid Cancer, Radiation Therapy Planning, Infection/Inflammation, Colorectal Cancer, and more!

This issue of PET Clinics examines PET/CT Imaging in Tracers Beyond FDG. Article include standardization and quantification in PET/CT imaging: tracers beyond FDG; 18F NaF PET/CT imaging; 18F NaF PET/CT imaging in pediatrics; choline PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; DOPA PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; 68 GaSSRTs PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; FLT PET/CT imaging for the head and neck, thorax, abdomen, and pelvis; hypoxia tracers; PET/MRI tracers beyond FDG: current status and future aspects; PET/CT normal variations: effect of novel quantitative approaches; and more!

This two-part issue, edited by Dr. Rathan Subramaniam, reviews current clinical information in "PET/CT and Patient Outcomes." In Part II of this issue, articles will include: Hepatobiliary and Pancreatic Cancer; Endometrial, Cervical & Ovarian Cancer; Renal, Bladder and Testicular Cancer; Musculoskeletal and Soft Tissue Tumors; Myocardial Perfusion / Viability; Unknown Primary Cancer; Gastric Cancer; Brain Tumors; Neuroendocrine Tumors, and more!

This issue, edited by Dr. Rakesh Kumar, reviews current clinical information in "PET Based Interventions." Articles will include: PET/CT in Radiofrequency Ablation; PET/CT Guided FNAC/Biopsy; PET/CT in Radiotherapy Planning; Dual Time Point Imaging; The Role of PET in Radiation Oncology; PET/CT in Individualization of Treatment (Personalized medicine); Ga68-DOTA-TOC PET/CT in targeted radionuclide therapy (Lu188 therapy for NET); Role of FDG PET/CT in Targeted Radionuclide Therapy of Endocrine Malignancies; Overview of Conventional Imaging Based Intervention in Clinical Practice; Special Techniques in PET/CT in Evaluating Genito-urinary Malignancies; and more!

This issue of PET Clinics examines normal variations and benign findings in FDG PET/CT Imaging. Topics include Standardization and quantification in FDG PET /CT imaging for staging and restaging of disease, dynamic changes in FDG update in normal tissues, as well as normal variations in the brain, head and neck, thorax, abdomen, pelvis, and in pediatrics.

Nuclear Medicine has greatly contributed to the diagnosis and treament of neuroendocrine neoplasms. This issue of PET Clinics will focus not only on the diagnosis and treatment of neuroendocrine tumors, but also theranostics. Topics include SPECT and other PET tracers, F-DOPA, Ga-DOTA-peptides, Yttrium- and Lutetium-based therapy, and the role of FDG PET. It also covers key information of theranostics.

This issue of PET Clinics focuses on Evolving Role of PET-guided Interventional Oncology Based Procedures, and is edited by Drs. Abass Alavi (the Consulting Editor of PET Clinics), Marnix Lam, Stephen Hunt, and Ghassan El-Haddad. Articles will include: Y-90 PET/CT and radioembolization; FDG-PET and radioembolization; Ga-68-PSMA PET and HCC; C11 Acetate-PET for hepatocellular carcinoma patients undergoing radioembolization; FDG-PET for Ablation Treatment Planning, Intraprocedural Monitoring and Response; Global FDG Response Assessment to IR Procedures with Concomitant Immunotherapy; PET Assessment of Abscopal Effects and Pseudoprogression from IR Procedures; FDG-PET for monitoring response to embolotherapy (TACE) in primary and metastatic liver disease; and more!

Editor Hersh Chandarana, MD and authors review Advanced MR Imaging in Clinical Practice. Articles will include: Current Status of Diffusion Weighted Imaging; Current Status of Perfusion Weighted Imaging; Non-gadolinium Enhanced MR Angiography; Pearls and Pitfalls of 3 T imaging; Implementing MR Neurography in Clinical Practice; Imaging around Hardware and Metal; Recent Advances in T1- and T2-Weighted Imaging of the Abdomen and Pelvis; Recent Advances in Neuro and Spine Imaging; Advances in MR Hardware and Software, and more!